Russell Investments Group, Ltd. - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 77 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2020$21,000
-4.5%
5,5680.0%0.00%
Q3 2020$22,000
-4.3%
5,5680.0%0.00%
Q2 2020$23,0005,5680.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,138,893$123,256,00018.11%
Broadfin Capital, LLC 1,656,720$49,337,0007.69%
SECTORAL ASSET MANAGEMENT INC 1,128,219$33,598,0003.68%
Perceptive Advisors 4,313,611$128,459,0003.60%
RTW INVESTMENTS, LP 1,122,540$33,429,0003.18%
Asymmetry Capital Management, L.P. 55,864$1,664,0002.08%
EMORY UNIVERSITY 77,335$2,303,0001.64%
Monashee Investment Management LLC 185,000$5,509,0001.52%
SPHERA FUNDS MANAGEMENT LTD. 260,000$7,743,0001.18%
Stanley-Laman Group, Ltd. 167,825$4,998,0001.14%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders